Sopharma Group Ltd.


What we do
Develop, manufacture and deliver affordable treatment to millions of patients.

Integrated model

We are a leading producer and distributor of health related products. Our business model is vertically integrated running through the whole value chain.
Sustainable Development

Our cost structure coupled with the know-how and GMP certifications of our production facilities enable us to offer high quality competitively priced products. We aim at providing more accessible and affordable treatment than our competitors.

We have a strong potential for further development on Sopharma’s own traditional herbal products in the long-term. The first such product registered on the Austrian market was Nivaject, the injectable form of Nivalin (galantamin).

Showing the single result